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Background: In South Africa, poverty and the dual epidemics of HIV and tuberculosis underscore the need for
prevention efforts for obesity. The aim of this study was to describe the prevalence of obesity in a cohort of South
African women and discuss the implications for public health practices.
Methods: A total of 5,495 HIV-negative women from KwaZulu-Natal, South Africa enrolled in three microbicide trials
during the period of 2002–2008 were categorised as normal weight (body mass index (BMI: 18.6-<25), overweight (BMI:
25-<30) or obese (BMI: 30+). Incidence of HIV and other sexually transmitted infections such as Chlamydia and
gonorrhoea were also estimated and compared by BMI groups. Combined data was analysed using STATA 10.0.
Results: Approximately 70% of the sample population was classified as being overweight or obese. Older age and lack
of education were determined to be significant predictors of obesity. Women who were 35 years or older were more
than three times as likely to be overweight and more than 12 times as likely to be obese compared to the youngest
group. The highest HIV and STI incidence rates were observed among those with BMI <25 kg/m2 (normal weight)
compared to women with BMI more than 25 kg/m2 (8.1 and 19.8 per 100 person-year respectively, P<0.001, both).
Conclusion: Effective obesity prevention strategies are needed to re-formulate HIV prevention programmes by
incorporating healthy diet and life style messages to target those who are at highest risk not just for HIV infection but
also for non-communicable diseases.
Keywords: Body mass index, Sexual risk behaviours, HIV, South AfricaBackground
Obesity plays a major role in chronic non-communicable
diseases, including type-2 diabetes, cardiovascular disease
(CVD), and hypertension [1]. Globally, 1.3 billion people
are estimated to be overweight or obese [2]. Obesity is not
only affecting developed countries but is becoming an
increasing problem in developing countries [3-5]. There
has been a progressive increase in the prevalence of obesity
in South Africa, particularly among women and young girls* Correspondence: hwand@kirby.unsw.edu.au
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distribution, and reproduction in any medium[6-8]. A report published by the South African Medical
Research Council (MRC) in 2007, cited that “56% of adult
women and 29% of adult men were overweight/obese,
while 17% of children under the age of 9 years were over-
weight” [7,9]. The MRC also reported that “approxi-
mately 60 people die from obesity-related disease every
day in South Africa”. The primary reason for these high
figures, particularly among black women, may be a
number of misconceptions regarding the health risk of
obesity, including the strong belief that increased body
weight is an indication of a good state of health [10,11].
In addition, research conducted in the US indicates that
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factors, including the absence of accessible retailers of
quality food in economically depressed or rural areas
[12]. Similar phenomena could also be relevant to the
South African situation.
South Africa is a developing country with a high preva-
lence of poverty [13]. Other factors such as violence, lack
of education and inadequate services contribute to the in-
creasing number of cases of non-communicable as well as
communicable diseases [14,15]. South Africa bears the
largest global burden of the HIV epidemic, with an
estimated population of 5.7 million individuals living with
the virus [16], and the third highest number of incident
tuberculosis cases. The prevalence of obesity, particularly
among black South African women, reflects globalisation,
which is the primary driving force behind the changes in
healthy diet and life style (i.e. nutritional transition) [17].
Developing and implementing obesity prevention programs
will present numerous challenges in many South African
communities where HIV, tuberculosis and poverty are
pervasive, and access to a nutritionally balanced food sup-
ply is limited [3].
The HIV Prevention Research Unit of the Medical Re-
search Council in Durban, KwaZulu-Natal, has been
involved in several biomedical intervention clinical trials
in HIV prevention. It has recruited more than 15,000
women. Counselling sessions associated with these trials
educate women on how to protect themselves against
HIV infection [18,19]. However, healthy diet and life
style messages have never been incorporated into these
programs.
The primary aim of this paper was to estimate the
prevalence of obesity among a cohort of women, who
enrolled in one of the three biomedical intervention
trials during the period of 2002–2008 at clinical research
sites in KwaZulu-Natal, South Africa. We also compared
HIV seroconversion rates and other sexually transmitted
infections across the women who were classified as nor-
mal, overweight and obese. Therefore implementing
healthy diet and life style messages into these programs
will create a unique opportunity (without an extra cost)
to target those who are at most risk for obesity.
Methods
Participants and design
The current study included data derived from three bio-
medical intervention trials. Details of the main trials
have been published elsewhere [20-22]. The present
analysis included 1,485 women who enrolled in the
Methods for Improving Reproductive Health in Africa
(MIRA) trial of the diaphragm for HIV prevention
(2002–2005). The Microbicides Development Programme
(MDP) 301 study was a multi-centre, phase III,
randomized, double-blind, and parallel group trial of avaginal microbicide (2005–2008); we included 2,554
women who enrolled in MDP 301. The candidate
microbicide Carraguard (PC-515), developed by the Popu-
lation Council, was a non-contraceptive vaginally applied
gel. Its efficacy against HIV infection was investigated in a
randomized, placebo-controlled, double-blind, phase III
trial (2004–2007). The present analysis included data from
1,456 women who enrolled in the Carraguard trial.
All protocols and informed consent forms were
approved by the Biomedical Research Ethics Committee
at the University of KwaZulu-Natal, as well as the vari-
ous study-specific Institutional Review Boards.Measurements
The majority of the demographic information was
collected by face-to-face interview. Body mass index
(BMI) (kg/m2) was calculated based on clinically
assessed weight (kg) and height (m) at baseline and
month 12. The current analysis considered only the
baseline measurements as there was no notable change
with regard to BMI during the follow up across the
trials. WHO definitions were used to categorize women
as normal weight (BMI: 18.5–24.9), overweight (BMI:
25–29.9) and obese (BMI: 30 and above). Age was strati-
fied into 4-year categories: 18–24 years, 25–29 years,
30–34 years, and 35+ years. Women were also
categorized based on their self-reported level of educa-
tion (less than high school vs. at least high school or
higher) and employment status (regular income vs.
none/irregular income).Statistical analyses
Demographic and sexual history variables were described
by BMI groups. We used logistic regression models to test
for the effect of age groups, level of education and
employment status in obese (versus normal weight) and
overweight (versus normal weight) women separately.
Kaplan-Meier survival analyses were conducted to
estimate the proportion of women acquiring HIV infec-
tion and STIs during the study. Seroconversion date was
estimated as the midpoint between the first visit date at
which the woman tested positive for HIV and the previ-
ous negative test date. Time to seroconversion was
defined as the difference between the seroconversion
date and the enrolment date.
Cox proportional hazard regression models were used
to determine the association between baseline BMI and
incidence of HIV and STIs. We also reported age
adjusted analysis; however, since the primary sexual risk
factors were not collected in a consistent way it was not
possible to combine them across the trials. Therefore we
did not perform multivariate analyses in this combined
population.
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(College Station, TX, USA).Results
Respondents were described overall and across the BMI
categories in terms of age, level of education and em-
ployment status (Table 1). Of 5,495 women, 1,790 (32%)
had a BMI less than 25 (normal weight), 1,739 (32%)
had a BMI between 25 and 29 (overweight) and 1,966
(36%) had a BMI of 30 or more (obese). Overall, the me-
dian age was 27 (inter-quartile range [IQR]:22–37). The
median age in the three BMI weight groups (normal
weight, overweight, and obese) were 22 (IQR: 20–28), 27
(IQR: 22–36), and 34 (IQR: 26–40) years, respectively.
Proportions of women reported completing high school
were 36%, 30% and 23% for normal weight, overweight
and obese women respectively; employment rates were
reported as 15%, 20% and 22% for normal weight, over-
weight and obese respectively.
The data showed a significant age effect (Table 1).
Women who were 35 years or older were more than
three times as likely to be overweight and more than 12
times as likely to be obese compared to the youngest
group (i.e. <25 years) [Odds Ratio (OR): 3.35, 95% Confi-
dence Interval (CI): 2.79-4.01 and OR:12.56, 95% CI:
10.44-15.10 respectively]. Women who had less than
high school education were approximately 50% more
likely to be overweight or obese compared to those who
had completed high school (OR: 1.47, 95% CI:1.27-1.70
and OR: 1.59, 95% CI: 1.38-1.83). Overweight and obese
women were more likely to report a regular income









All women 100% 32% 32%
Age, median (IQR) 27 (22–37) 22 (20–28) 27 (22–36)
<25 2203 (40%) 1,147 (64%) 694 (40%)
25-29 908 (16%) 273 (15%) 316 (18%)
30-34 700 (13%) 129 (7%) 241 (14%)
35+ 1684 (31%) 241 (13%) 488 (28%)
Education level
At least high school 1649 (30%) 644 (36%) 522 (30%)
Less than high
school
3846 (70%) 1146 (64%) 1217 (70%)
Employment status
Yes 1044 (19%) 161 (15%) 348 (20%)
No 4451 (81%) 1529 (85%) 1391 (80%)95% CI: 1.14-1.72 and OR: 1.61, 95% CI: 1.32-1.96
respectively).
HIV and sexually transmitted infection incidence
rates were determined by BMI group during the study
(Table 2). The highest HIV and STI incidence rates
were observed among those with BMI <25 kg/m2
(normal weight) (8.1 and 19.8 per 100 person-year re-
spectively) compared to women with BMI more than
25 kg/m2 (P<0.001, both). Adjusted and unadjusted
hazard ratios (HR) and associated 95% Confidence
Intervals (CIs) are presented in Table 2. After
adjusting for age, only those with a baseline BMI 25–
29 kg/m2 were more likely to HIV seroconvert
compared to those in the BMI 30 kg/m2 or more.
The estimated relative risk of STIs during the trial
was also progressively higher in the overweight and
normal weight group compared to obese women.
Discussion
Our study confirms an extremely high prevalence of over-
weight or obesity in this reasonably large cohort of women.
Approximately 70% of the women were categorized as
being overweight or obese indicating an alarming health
concern in this population. This is slightly higher than
overall figures reported for South Africa, and is the highest
found among other African countries [6-9].
Our study found approximately 50% of the obese
women were older than 35 years of age. This strong link
between obesity and age suggests that it might be vital
to discuss healthy diet and body weight issues at the
same time as issues of sexuality and sexual risk with










34 (26–40) - -
362 (18%) 1 1
319 (16%) 1.91 (1.59,2.31) 3.70 (3.03,4.52)
330 (17%) 3.09 (2.44,3.90) 8.11 (6.41,10.26)
955 (49%) 3.35 (2.79,4.01) 12.56 (10.44,15.10)
452 (23%) 1 1
1514 (77%) 1.47 (1.27,1.70) 1.59 (1.38,1.83)
433 (22%) 1 1
1533 (78%) 1.40 (1.14,1.72) 1.61 (1.32,1.96)
Table 2 Incidence of HIV infection and sexually transmitted infections by BMI
At enrolment HIV incidence (6.7 per 100 person year, 95% CI: 6.1-7.4 per 100 person year)
Crude incidence rate per 100 Person
Year (95% CI)
p-value† Unadjusted Hazard Ratio
(95% CI)






Obese1 4.6 (3.8,5.6) 1 1
Overweight2 7.8 (6.7,9.0) 1.70 (1.33,2.17) <0.001 1.36 (1.06,1.75) 0.015
Normal3 8.1 (7.0,9.4) 1.76 (1.38,2.25) <0.001 1.19 (0.92,1.55) 0.185




Obese1 10.9 (9.6,12.3) 1 1
Overweight2 16.6 (15.0,18.4) 1.82 (1.55,2.14) <0.001 1.46 (1.22,1.75) <0.001
Normal3 19.8 (17.9,21.9) 1.55 (1.31,1.83) <0.001 1.40 (1.18,1.66) <0.001
† P value for log rank test.
‡ Age adjusted.
‡‡ Chlamydia trachomatis and gonorrhoea.
1 30+ BMI, 2 (25-<30) BMI, 3 (18.6-<25) BMI.
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lence of obesity in South African women. In South
Africa, poverty and the twin epidemics of HIV and tu-
berculosis mean that prevention efforts for obesity may
not have the highest priority. However, evidence
suggests that, just like in the developed world, obesity
and its co-morbidities are adversely affecting the lives of
South Africans and the consequent burden of disease
contributes to the increasing cost of health care. We rec-
ommend identifying effective obesity prevention strategies
and integrating them into HIV prevention and manage-
ment programmes as a component of the interventions
needed to enhance the overall health of the population.
Implementing healthy diet and life style messages into up-
coming HIV/AIDS prevention programs will be beneficial
without an extra cost. However, large scale prevention
efforts are needed to help control the epidemic. Recently,
a survey (The South African National Health and Nutri-
tion Examination Survey – SANHANES-1) was planned
for 2011–2012 to evaluate the health status of South
Africans for non-communicable diseases, particularly
those associated with diet and life style [23]. Results from
the SANHANES-1 will inform the size of the problem
among South African men and women.
Our study has several limitations. First, the data used
in this study were taken from a cohort of women who
participated to HIV prevention trials. Therefore, there
may be selection bias of women willing to engage in
clinical trials such as the ones included in this study.
Second, primary sexual risk factors were measured dif-
ferently at different time points across the trials
considered in this study. Therefore, we did not assess
the variables that may have explained the relationship
between body weight and sexual risk. Consequently, it ispossible that being overweight and being at risk for HIV
or STIs are due to unmeasured covariates which is not
the scope of the current study. Finally, information on
nutritional and/or physical activity status was not
collected in these trials.
Nevertheless, this study found significant associations;
the hazard ratios demonstrated reasonably large effect
sizes indicating a strong signal regarding these
associations. Finally, since this is a secondary analysis,
we did not determine statistical power a prior to the
study. Well-designed studies with adequate power are
necessary to answer the predictors of the obesity among
women in South Africa.
Conclusions
Current study presented evidence for unacceptable high
rates of obesity among South African women and our
study adds new evidence using data from more than 5,000
women; while while this group is at higher risk for non-
communicable diseases compared to women of normal
weight, normal weight women were at increased risk for
communicable diseases compared to those who were
overweight or obese. New strategies are needed to re-
formulate existing HIV prevention and treatment
programs by incorporating information on a healthy diet
and lifestyle to produce holistic health and wellness
interventions.
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